Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India

Eliminating visceral leishmaniasis in South Asia: the road ahead

(2019) Suman Rijal et al.   BMJ-British Medical Journal

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis

(2019) Joyce Pijpers et al.   PLoS Neglected Tropical Diseases

Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh

(2019) Dinesh Mondal et al.   PLoS Neglected Tropical Diseases

Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post–Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh

(2018) Margriet den Boer et al.   CLINICAL INFECTIOUS DISEASES

Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies

(2018) Dinesh Mondal et al.   CLINICAL INFECTIOUS DISEASES

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India

(2018) Vishal Goyal et al.   PLoS Neglected Tropical Diseases

The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh

(2018) Lloyd A. C. Chapman et al.   PLoS Neglected Tropical Diseases

Chemotherapeutics of visceral leishmaniasis: present and future developments

(2017) SHYAM SUNDAR et al.   PARASITOLOGY

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.

(2017) Eduard E. Zijlstra et al.   PLoS Neglected Tropical Diseases

Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India

(2016) H. Kaushal et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent

(2015) Graham F. Medley et al.   NATURE

Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia

(2014) Bart Ostyn et al.   PLoS One

Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

(2014) Sakib Burza et al.   PLoS Neglected Tropical Diseases

Clinical and Immunological Aspects of Post–Kala-Azar Dermal Leishmaniasis in Bangladesh

(2013) Shamim Islam et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis

(2012) Thomas P. C. Dorlo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Post-Kala-Azar Dermal Leishmaniasis in a Patient Treated with Injectable Paromomycin for Visceral Leishmaniasis in India

(2012) K. Pandey et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnosis of visceral leishmaniasis: developments over the last decade

(2011) Gurumurthy Srividya et al.   PARASITOLOGY RESEARCH

Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000–2010)

(2011) Surendra Uranw et al.   PLoS Neglected Tropical Diseases

Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh

(2010) Dinesh Mondal et al.   PLoS Neglected Tropical Diseases

Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine

(2009) D. Kumar et al.   ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY